<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00889213</url>
  </required_header>
  <id_info>
    <org_study_id>08D.229</org_study_id>
    <nct_id>NCT00889213</nct_id>
  </id_info>
  <brief_title>An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas</brief_title>
  <official_title>A Prospective Randomized Comparison of Pancreatic Stump Closure Techniques Utilizing an Autologous Falciform Patch and Fibrin Glue Compared to Standard Closure Following Distal Pancreatectomy With or Without Splenectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to determine whether the use of an autologous falciform ligament
      patch combined with fibrin glue will reduce the rate of pancreatic fistula in patients
      completing distal pancreatectomy. The hypothesis for the current trial is: Autologous
      falciform patch closure with fibrin glue will result in a 50% decrease in fistula formation
      postoperatively. The primary end point will be the development of pancreatic fistula using
      the ISGPF definition of pancreatic fistula1. (Drain output of any measurable volume of fluid
      on or after postop day #3 with an amylase content greater than three times serum amylase).
      Secondary end points will include length of postoperative hospital stay, percutaneous
      intervention rates, re-operation rates, morbidity to include delayed gastric emptying, wound
      infection, intraabdominal abscess, postoperative hemorrhage and 30-day mortality.(Bassi C,
      Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: An international study
      group (ISGPF) definition. The Journal of Surgery, 2005;138:8-13).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2008</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pancreatic fistula development post distal pancreatectomy</measure>
    <time_frame>30 days post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity- wound infection,delayed gastric emptying,abscess formation</measure>
    <time_frame>30 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical re-intervention/percutaneous interventions</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Pancreatic Fistula</condition>
  <condition>Distal Pancreatectomy Complications</condition>
  <condition>Falciform Patch Pancreatic Closure</condition>
  <condition>Fibrin Glue Pancreatic Closure</condition>
  <arm_group>
    <arm_group_label>Patch and glue arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized patients to the patch and glue arm will undergo placement of a falciform ligament tissue patch and fibrin glue to the resection margin of the remnant pancreas following distal pancreatectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>stapled /sutured pancreatic closure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Falciform patch and fibrin glue application</intervention_name>
    <description>Following standard surgical exploration, the pancreatic gland will be mobilized appropriately to the level of transaction in the pancreatic neck, body or tail. The gland may be divided by stapling device, electrocautery or sharp division. Suture material will be at the discretion of the surgeon but may include absorbable or non-absorbable braided on mono-filament. Those patients randomized to autologous falciform patch will have the falciform membrane harvested. The falciform patch will be laid over the suture line of the resected pancreatic stump and secured to the pancreatic capsule utilizing #4-0 PDS suture placed at 12, 3, 6, and 9 o'clock positions. Fibrin glue (Vitagel) will be utilized to fill the potential space within this membranous capsule. Fibrin glue will be prepared as per standard instructions. Drains will be placed in the splenic bed and/or adjacent to the stump of the pancreas for postoperative fluid evacuation.</description>
    <arm_group_label>Patch and glue arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>standard pancreatic closure</intervention_name>
    <description>Following standard surgical exploration, the pancreatic gland will be mobilized appropriately to the level of transaction in the pancreatic neck, body or tail. The gland may be divided by stapling device, electrocautery or sharp division. Suture material will be at the discretion of the surgeon but may include absorbable or non-absorbable braided on mono-filament.</description>
    <arm_group_label>stapled /sutured pancreatic closure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. completion of a successful distal pancreatectomy with/without splenectomy

          2. patient must have a pancreatic remnant in place

          3. there must be a viable falciform ligament for creation of the autologous patch

        Exclusion Criteria:

          1. patients undergoing total pancreatectomy

          2. patients undergoing distal pancreatectomy who have previously completed a right sided
             resection of the pancreatic head, uncinate and neck

          3. failure to sign informed consent

          4. pregnant patients

          5. patients in whom previous surgery has eliminated the falciform ligament, i.e. previous
             liver resection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ernest L Rosato, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ernest L. Rosato, M.D.</last_name>
    <phone>215-955-8666</phone>
    <email>ernest.rosato@jefferson.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey M Hardacre, MD</last_name>
      <phone>216-844-7047</phone>
      <email>jeffrey.hardacre@UHospitals.org</email>
    </contact>
    <contact_backup>
      <last_name>Bridget Ermlich, RN</last_name>
      <phone>(216) 844-3602</phone>
      <email>bridget.ermlich@UHospitals.org</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffrey M Hardacre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ernest L Rosato, M.D.</last_name>
      <phone>215-955-8666</phone>
      <email>ernest.rosato@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Ernest L Rosato, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles J Yeo, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Berger, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karen Chojnacki, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eugene Kennedy, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francis E Rosato, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernadette Profetta, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2009</study_first_submitted>
  <study_first_submitted_qc>April 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2009</study_first_posted>
  <last_update_submitted>August 5, 2014</last_update_submitted>
  <last_update_submitted_qc>August 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pancreatectomy</keyword>
  <keyword>fistula</keyword>
  <keyword>fibrin glue</keyword>
  <keyword>falciform patch</keyword>
  <keyword>surgery</keyword>
  <keyword>complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Pancreatic Fistula</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancrelipase</mesh_term>
    <mesh_term>Pancreatin</mesh_term>
    <mesh_term>Fibrin Tissue Adhesive</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

